Jacobs Journal of Neurology and Neuroscience

An Acute Cerebellar Syndrome. Who Is Involved?

*Salimata Gassama
Department Of Neurology, Centre Hospitalo-Universitaire De Rouen, France

*Corresponding Author:
Salimata Gassama
Department Of Neurology, Centre Hospitalo-Universitaire De Rouen, France
Email:gassama.salimata@gmail.com

Published on: 2018-01-18

Abstract

Case Report: We report the case of a 79 year-old bipolar patient treated with Lithium who developed an acute cere-bellar syndrome following a Legionnellosis episode. Clinical evolution, biological exams, structural and functional imaging were all favoring a post-infectious disease.

Discussion: Cerebellar disorders in Legionnaire’s disease are considered an inflammatory process although patho-physiology remains poorly understood. Granting the recent studies on the role of lithium as neuropro-tective in neuroinflammation, we empirically hypothesized that lithium might have played a beneficial role in this case.

Conclusion: This case shows that FDG PET/CT can help confirm the diagnosis of post-Legionnella cerebellitis and should be easily prescribed in this indication. Furthermore, we suspect that Lithium might have a neu-roprotective effect in this post-infectious phenomena. Subarachnoid haemorrhage(SAH) accounts for approximately only 5% of strokes [1], yet occurs at a young age leading to lengthy burden. SAH outcomes research has rarely examined psychological outcomes, despite their prevalence and substantial contribution to recovery [2], and potentially to functional outcomes.

Keywords

Cerebellar Disorders; Legionellosis; Cerebellar Neurodegeneration; Acute Ataxia; Neu-roinflammation

Case Report

A 79 year-old man was admitted to our Neurology Department in May 2015 for an acute cerebellar syndrome. He had history of alcoholism, alcoholic Child-Pugh C13 cirrhosis, psoriasis, systemic hyper-tension and hypercholesterolemia. Usual treatments were Aldactone 25mg/day and Oxazepam 20mg/ day. The patient was fully independent before this episode. He had slight gait disturbances that had never been explored and walked with a stick. His Instrumental Activities of Daily Living (IADL) score was 6/6. On March 9th, he attempted suicide by ingesting a high dose of alcohol and several tab-lets of Clopidogrel and Domperidone. He was then hospitalized and diagnosed with Bipolar disorder. He was prescribed Quetiapine 400mg/day, Lithium Carbonate 800mg/day, Oxazepam 10mg/ day and B1/B6/PP vitamins.

One month later, he presented with isolated fever at 39.2°C. There was no specific signs of infection, ascites, encephalopathy, tremor, lithium or neuroleptic intoxication. EKG was normal. Chest X-Ray and thoracic CT showed a right pulmonary infiltrate. The lithium blood concentration dosage was in normal range at 0.78 mmol/L (N=0.6-1.2 mmol/L). Neuroleptics and Benzodiazepines were stopped and lithium was kept at the same dose. Streptococcus pneumoniae and Legionnella pneumophila urinary antigens were assayed and a large spectrum antibiotherapy was introduced (Ceftriaxone 1g/day and Metronidazole 500mg x3/day). Since pneumonia symptoms persisted, the antibiotherapy was switched to Piperacilline-Tazobactam 4g x3/day and Amikacine 1g/day 3 days after. Finally, on Day 4, hypoxemia severely worsened and the patient was transferred to the Respiratory Intensive Care Unit.

He received noninvasive ventilation and high flow oxygen therapy. The Legionnella pneumophila urinary antigens assay came back positive. The antibiotherapy was eventually changed to Levofloxacine 500mg 2/day. The evolution was favorable and he was transferred to a traditional Pneumology unit.

Fifteen days after the initial fever, the patient developed a severe cerebellar syndrome overnight. There was neither confusion, nor tremor, nor oculomotor disturbances, nor fever. Blood tests showed de-creased inflammatory markers. HeadCT showed no sign of hemorrhage. Lithium blood concentration was below therapeutic range and was highly monitored. The patient was transferred to our Neurology Department. At the admission, he showed a severe cerebellar syndrome (cerebellar ataxia and dysar-thria). The severity was 31 on the Scale for Assessment and Rating of Ataxia (SARA) [1]. He was con-scious and oriented. Biological screening was normal. Brain Magnetic Resonance Imaging (MRI) showed diffused encephalic atrophy, but neither significant hypersignal on Diffusion, FLAIR, T2*, Time Of Flight weighted images, nor Gadolinium contrast lesions on the initial MRI, nor on the 4th week control. CSF analysis was normal. Onconeuronal antibodies were negatives. EEG showed diffuse slow waves predominantly in anterior regions compatible with encephalopathy.

Finally, a FDG PET/CT showed notable hypometabolism of both cerebellar hemispheres, respecting the vermis, compatible with a post-infectious disease (Figure 1). We confirmed the diagnosis of acute cere-bellitis secondary to Legionella pneumophila. One month after the onset, the patient was still dysarthric but intelligible.

Figure 1:

Figure 2:

He showed significant clinical improvements and could circulate with a walker. SARA was then 16. The patient was eventually discharged and successfully returned home.

Discussion

Legionnellosis is an unfrequent but grave infectious disease with high morbidity and mortality. Neuro-logical symptoms such as confusion, disorientation, stupor and coma are common extrapulmonary signs in this disease (up to 40-50%) [2]. Cerebellar dysfunction associated with Legionnellosis’ incidence has been estimated to 3.7% among one of the earliest cohorts of Legionnaire’s disease patients [2].

In our case, the difficulty was to determinate the origin of the acute cerebellar syndrome. We ruled out lithium toxicity since the patient clinically improved and never showed any toxicity symptoms while treated with Lithium Carbonate. This aspect was not reported in any Lithium induced cerebellar syn-drome published cases [3]. Our patient’s brain MRI did not show any specific lesions, nor signs of Gay-et-Wernicke encephalopathy, nor Acute Disseminating Encephalomyelitis (ADEM) which latter have been associated with Legionella Encephalopathy in numerous recent case reports [4]. Other key ele-ments were the absence of meningitis arguments which excluded a direct bacterial aggression and the PET-FDG/CT outcome which showed non-systemic focal hypometabolism defects compatible with post-infectious sequels. Functional imaging is more sensitive than structural MRI when it comes to in-flammatory lesions. [5,6] In FDG-PET/CT, hypermetabolic changes occur in acute inflammatory le-sions and hypometabolic changes in inflammatory sequels [7]. Although we cannot confirm postLegionella cerebellitis based on the unique FDG PET/CT, the body of arguments from clinic to func-tional and structural imaging asserts our hypothesis.

Physiopathology of cerebellar dysfunction in Legionnaire’s disease remains unknown. Most patients with cerebellar syndrome associated with Legionellosis suffer severe dysarthria and ataxia sequels with modest clinical improvements. [8] Since normal CSF, normal brain imaging (CT and MRI) and slow-waving encephalopathy signs on EEG are usually found, it has been postulated that an indirect inflam-matory reaction involving Lipopolysaccharide (LPS) endotoxin may be the reason of this rare affection [9,10]. LPS is the major immunodominant antigen of Legionella pneumophila and all Legionella species. [11] Activation of microglia precedes and triggers neuronal death.[12] Recent studies have shown that lithium can be neuroprotective by reducing microglial migration, hence, inflammation induced neurotoxicity. [13] Dong et al. showed that lithium reduces lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 (TLR4) expression by activating a specific intracellular pathway.[14] Surprisingly, our 79 year old patient showed significant clinical improvements of his cerebellar symptoms with moderate sequels. We hypothesized that lithium might have played an anti-inflammatory action in this case by reducing neurotoxicity in this acute cerebellitis postLegionellosis. However further experimental studies should confirm this hypothesis in order to elucidate eventually new therapeutic solutions for this highly disabling affection.

Conclusion

This case report is, to our knowledge, the first to show that FDG PET/CT can help confirm the diagnosis of postLegionnella cerebellitis and should be easily prescribed in this indication. Furthermore, we suspect that Lithium might have a neuroprotective effect in this post-infectious phenomena.

Funding Statement

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Competing Interests Statement

There are no competing interest to declare.

Contributorship Statement

Salimata Gassama is a medical intern who wrote and designed the submitted article, acquired and interpreted data, participated in the patient’s medical care during the entire hospitalization in Neurology until he was discharged.

Dr. Damien Fetter is a senior Neurologist who supervised the patient’s medical care during the entire hospitalization in Neurology until he was discharged and revised the article critically for important intellectual content.

Prof. Xavier Monnet is an ICU Professor who revised the article critically and significantly, and contributed in the conception of the short report, especially on the critical care and pneumology aspects.

Dr. Bertrand Bourre, is a senior Neurologist specialised in Neuroinflammation who revised the article critically, especially on the neuroinflammation aspect of this report.

Dr. Mathieu Chastan is a Senior Nuclear Medicine radiologist who interpreted the patients FDG-PET/CT and revised the article critically.

Prof. David Maltête is a Neurology Professor who revised the article critically.

Prof. Didier Hannequin is a Neurology Professor, head of the department of the neurology department in Rouen who contributed in the design of the work and revised the article critically.

Dr. Nicolas Mirlink is a Senior Neurologist who participated in the patient’s medical care during the entire hos-pitalisation in Neurology until he was discharged, critically revised the article and gave the final approval of the version published.

References

1.Schmitz-Hübsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006, 66(11): 1717-1720.

2. Johnson JD, Raff MJ, Van Ardsall JA. Neurologic manifestations of Legionnaires’ disease. Medicine (Balti-more). 1984, 63(5): 303-310.

3. Porto FH, Leite MA, Fontenelle LF, Marrocos RP, Szczerback NF et al. The Syndrome of Irreversible Lithi-um-Effectuated Neurotoxicity (SILENT) : One-year follow-up of a single case. J Neurol Sci. 2009, 277(1-2): 172–173.

4. De Lau LM, Siepman DA, Remmers MJ, Terwindt GM, Hintzen RQ. Acute Disseminating Encephalomyelitis Following Legionnaires Disease. Arch Neurol. 2010, 67(5): 623-626.

5. Morgan JC, Cavaliere R, Juel VC. Reversible corpus callosum lesion in legionnaires’ disease. J Neurol Neu-rosurg Psychiatry. 2004, 75(4): 651–654.

6. Imai N1, Yagi N, Konishi T, Serizawa M, Kobari M. Legionnaire’s disease with hypoperfusion in the cerebel-lum and frontal lobe on single photon emission computed tomography. Intern Med. 2008, 47(13): 1263-1266.

7. Meyer MA, Hubner KF, Raja S, Hunter K, Paulsen WA. Sequential positron emission tomographic evalua-tions of brain metabolism in acute herpes encephalitis. J Neuroimaging. 1994, 4(2): 104-105.

8. Shelburne SA, Kielhofner MA, Tiwari PS. Cerebellar involvement in legionellosis. South Med J. 2004, 97(1): 61-64.

9. Weir AI, Bone I, Kennedy DH. Neurological involvement in legionellosis. J Neurol Neurosurg Psychiatry. 1982, 45(7): 603- 608.

10. Sauchelli DO, DePascale GE, Servidei SE, Scoppettuolo G, Frisullo G et al. Neurological involvement during legionellosis, look beyond the lung. J Neurol. 2012, 259(10): 2243–2245.

11. Ciesielski CA, Blaser MJ, Wang WL. Serogroup specificity of Legionella pneumophila is related to lipopoly-saccharide characteristics. Infect Immun. 1986, 51(2): 397–404.

12. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005, 76(2): 77–98.

13. Beurel E, Yeh WI, Michael SM, Harrington LE, Jope RS. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J Immunol. 2011, 186(3): 1391-1398.

14. Dong H, Zhang X, Dai X, Lu S, Qian Y et al. Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/ FoxO1 pathway. J Neu-roinflammation. 2014, 11:140.